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HAL Id: hal-00552337 https://hal.archives-ouvertes.fr/hal-00552337 Submitted on 6 Jan 2011 HAL is a multi-disciplinary open access archive for the deposit and dissemination of scientific research documents, whether they are published or not. The documents may come from teaching and research institutions in France or abroad, or from public or private research centers. L'archive ouverte pluridisciplinaire HAL, est destinée au dépôt età la diffusion de documents scientifiques de niveau recherche, publiés ou non, emanant desétablissements d'enseignement et de recherche français ouétrangers, des laboratoires publics ou privés. 3 Differentiated hepatocytes perform many complex metabolic processes including synthesis and secretion of plasma proteins, synthesis and storage of glycogen and detoxication of endogenous toxins and xenobiotics. To study the process of differentiation and to characterize the enzymatic activities in the hepatocytes two main categories of in vitro models have been developed over the past 20 years: the primary cultures of normal hepatocytes and the hepatoma cell lines. Human hepatocytes can be plated in culture conditions maintaining cell survival and expression of liver specific functions for several days to weeks [1] . Although, these models have proven to be relevant for studying some aspects of the liver biology such as induction of drug metabolism enzymes (DMEs) by xenobiotics, large variations in functional activities especially for cytochrome P450 enzymes (CYP) have been observed in human hepatocytes isolated from different donors [1] . In addition, the relative shortage and unpredictable availability of human biopsies along with the limited growth activity and lifespan of hepatocytes in primary culture limit the use of these models.
Alternatively, hepatoma cell lines have been established from differentiated hepatocellular carcinomas that retain various expression levels of liver specific proteins. These cells contain low CYP activities [2] , which limits their use for studying liver metabolism and toxicity of xenobiotics.
Enforced expression of CYPs has been obtained in hepatoma cells by transient or stable transfection of expression vectors encoding the CYPs themselves or liver-specific transcription factor such as C/EBP alpha [3] . Although these transfected cells are relevant models to identify DMEs involved in metabolism of new drugs, high expression levels of a limited number of transfected CYPs occur in absence of the full panel of DMEs from phases I, II and III required for the complete metabolism of xenobiotics as observed in the liver.
The human hepatoma cell line HepaRG derived from a hepatocellular carcinoma [4] circumvents these drawbacks by expressing most of the liver specific functions including high levels of the major CYPs such as CYP3A4 and CYP1A2 [5, 6] . Progenitors HepaRG cells that differentiate into hepatocyte-like cells also represent a unique in vitro cell system to investigate the process of differentiation from hepatic progenitor cells towards hepatocyte-like cells [7] as well as the phenomenon of transdifferentiation from hepatocyte to biliary phenotypes or vice versa [7] . In addition, this hepatoma cell line provides a valuable in vitro model for investigating replication of the 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 [4] , drug metabolism [5, 6, 8] as well as studies of genotoxic compounds [9] .
However, the relatively low levels of the CYP2E1 enzyme in HepaRG cells [5, 6] limit their use for analyzing biotransformation of xenobiotics specifically metabolized by this DME. The CYP2E1 plays a major role in the metabolism of many xenobiotics in all humans [10] . Thus, expression of higher levels of CYP2E1, achieved by transfection in differentiated HepaRG cells, would be particularly useful to complete the pathways of biotransformation in these cells.
It is generally accepted that hepatic cells, especially primary hepatocytes, are difficult to transfect [11] . Liposome mediated transient transfection using the most recent cationic lipids allowed gene delivery in 10 to 30% of rodent and human hepatocytes in primary culture. These protocols were useful to study regulatory gene sequences [11] but remained of limited help to study the effect(s) of enforced expression of gene of interest in whole cell populations because of the relatively low rate of transfection.
Because of the raising interest in HepaRG cells for drug metabolism studies and for analyzing the process of differentiation from hepatic progenitors towards hepatocytes, optimization of HepaRG cell transfection has become a pertinent task. The aim of this work was first to establish efficient protocols of transfection of both progenitor and differentiated HepaRG cells, then to achieve enforced expression of CYP2E1 protein.
The HepaRG cells are available from Dr. Guillouzo (christiane.guillouzo@univ-rennes1.fr) for academic laboratories and from Dr. Chesné (christophe.chesne@biopredic.com) for industrial laboratories. Progenitor HepaRG cells were cultured as previously described [4, 5, 7] . For full expression of liver specific genes in hepatocyte-like cells, the culture medium was supplemented with 2% DMSO for 2 more weeks [5] .
A panel of commercial transfection reagents (Supplemental data S1) and the pEGFP-C3 (Clontech, Saint Germain en Laye, France) expression vector encoding the Green Fluorescent Protein (GFP) were used to transfect HepaRG cells. GFP positive cells were detected 48 h after transfection using the FC500 cytometer (Beckman Coulter, France). The mean of fluorescence (Geo mean) was determined for the GFP positive cell population. To determine background fluorescence, HepaRG cells were transfected with the non coding pC3 plasmid (pEGFP-C3 lacking the GFP cDNA). Cell In progenitor HepaRG cells, Lipofectamine 2000 ® was the most potent transfection reagent with an efficiency reaching 25% of GFP positive cells but with a strong toxicity. Other reagents allowed GFP expression in only 10 to 15% of cells. In differentiated hepatocyte-like cells, transfection rates were even lower (1 to 14%) than in progenitor cells (Supplemental data S1).
We next evaluated the lipophosphonates GLB43 and EG316 and lipophosphoramidates KLN25, KLN47 and BSV10 ( Figure 1 ) [12, 13] . We also evaluated the MM18 compound belonging to a family of glycine betaine lipids efficient for transfection in mouse hepatocytes [14] . The lipophosphonates GLB43 and EG316, lipophosphoramidates KLN47 and BSV10 have been previously reported [12] . For the KLN25 and the glycine betaine MM18 [13] , the synthesis are detailed in Supplemental data S2 and S3. All lipids are presented in Supplemental data S4 and the preparation of liposomes is described in Supplemental data S5. Transfections with the lipophosphonates, lipophosphoramidates and the MM18 produced by the IBiSA plateform "SynNanoVect" from Biogenouest® (France) were performed using 10 5 cells/well (in 24-multiwells) plated 24 h prior transfection. Liposome suspensions (10 mg of lipids/mL) were sonicated using an ultrasound water bath sonicator for 5 minutes. Liposomes and plasmids (0.5µg) were diluted in 100 µL OptiMEM medium (Gibco) prior mixing DNA plasmid dilution with liposome suspension. The resulting lipoplex solutions were vortexed for 30 seconds, incubated at room temperature for 30 minutes, added dropwise to the culture medium of HepaRG cells deprived in antibiotics and incubated for 4 hours with cells prior culture medium renewal.
A broad range of charge ratios from 0.5 to 16 was tested with 0.8 µg of DNA plasmid ( Figure   1 ). Different liposomal compositions were also studied including either the cationic lipid alone or associated with the neutral co-lipids DOPE or cholesterol, known to promote fusion between the lipoplexe and cellular membranes and to increase lipoplexe stability, respectively. The KLN47 was For the EG316, GLB43 and KLN25 liposomes ( Figure 1A , B and C), the highest transfection efficiencies in progenitor HepaRG cells were 16 ± 3, 14 ± 1 and 7 ± 1%, respectively, at the optimal charge ratio of 2. The cell viability decreased with high charge ratio. With BSV10 lipid ( Figure 1D ), the percentage of GFP positive cells increased proportionally to the charge ratio up to ~20% at the ratios 8 and 16 but was associated with low cell viabilities. MM18 lipid was the less efficient compound (~5% of GFP cells) with reduced cell viability at high charge ratios ( Figure 1E ). The KLN47 compound allowed the highest gene transfer in HepaRG cells with efficiencies up to 45% for the charge ratio of 4 with cell viability down to ~60% of control culture ( Figure 1F ).
Combining lipids EG316, GLB43, KLN25, BSV10 to the co-lipid DOPE significantly improved transfection efficiencies of HepaRG cells (i.e. ~40% of GFP positive cells with BSV10-DOPE, ~80% cell viability at the charge ratio of 1). MM18 liposome formulation with 15% cholesterol also significantly increased the transfection rate up to 20% of GFP positive cells at the charge ratio of 2 ( Figure 1E ). The benefit of using the co-lipid DOPE is probably due to its ability to induce an intracellular transition of the liposome/DNA complex from a lamellar to a non-lamellar phase, which enhances DNA release. Similar experiments were also performed with differentiated HepaRG cells but none of these formulations gave transfection efficiencies higher than 10% (data not shown) and, thus, did not improve transfection rates obtained with commercially available reagents. In conclusion, the KLN47 and BSV10/DOPE formulations allowed high gene delivery in proliferating progenitors cells (~50%) but not in quiescent differentiated HepaRG cells in agreement with the fact that gene transfer by liposomes depend upon cell cycle [15] .
Then, we evaluated the Microporator MP100 from LabTech France (Paris) designed to deliver DNA into cells in suspension [note: the device originally engineered by Digital Bio (NanoEnTek Inc., Korea) is now commercialized as the Neon TM electroporator from Invitrogen (Carlsbad, USA)].
Progenitor HepaRG cells were detached by trysinization while differentiated HepaRG cells were selectively detached by mild trypsination at room temperature [7] . Cells were washed twice with PBS 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 In progenitor cells, 16 conditions gave transfection rates between 80 and 95% of GFP positive cells with cell viabilities ranging from 65 to 90% (Figure 2A ). Other settings led to lower transfection efficiencies, which, however, remained above 50% of GFP positive cells with high cell viability rates.
In hepatocyte-like cells, electroporation also allowed efficient DNA delivery and high expression levels of the GFP proteins since two conditions (C5 and 4) reached transfection and cell viability rates above 80% ( Figure 2B ). The other settings led to transfection efficiencies ranging from 25 to 78% with cell viabilities varying considerably.
These data demonstrated that in HepaRG cells, electroporation is a more efficient technology for gene delivery than the cationic lipids tested. However, the transfection using the lipophosphoramidate compounds KLN47 and BSV10 will be useful since gene delivery is performed 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Figure 3A ) and the lipids BSV10 and KLN47 ( Figure 3C ). For immunoblotting of the GFP (antibody:
T-19, sc5384, Santa Cruz Biotechnology), the CYP3A4 (antibody: AB1254, Chemicon), the CYP2E1 (antibody: Oxford Biomedical, USA) and the HSC70 (antibody: B-6, sc7298, Santa Cruz Biotechnology), cells were lysed in 50 mM Hepes pH 7.9, 150 mM NaCl, 0.1 mM EDTA, 10% glycerol, 0.5% Tween 20 supplemented with protease inhibitors (EDTA-free, Roche). Ten µg of total 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 As expected, we evidenced that CYP2E1 and CYP3A4 were undetectable in progenitor cells while hepatocyte-like cells expressed high levels of CYP3A4 and low amounts of CYP2E1 ( Figure   3A ). In contrast, progenitors and differentiated HepaRG cells electroporated with the CYP2E1 vector expressed much higher levels of this DME while the CYP3A4 level in hepatocyte-like cells was not affected by electroporation ( Figure 3A) . Interestingly, the highest levels of GFP and CYP2E1 were observed in hepatocyte-like HepaRG cells although the percentages of GFP positive cells are very similar in both progenitor and differentiated cells (Figure 2 ). This is most likely due to the high overall protein synthesis in differentiated versus progenitor cells. Importantly, the CYP2E1 expression level in transfected cells was correlated with a ~5 to 6 fold increase in the CYP2E1-specific enzymatic activity compared to the activity in the control cells ( Figure 3B ).
We also evidenced the expression of the GFP and CYP2E1 proteins in the progenitor cells transfected with the BSV10/DOPE formulation and in a much lesser extend with the lipid KLN47 ( Figure 3C ). However, in differentiated cells, we did not observe any significant increase in CYP2E1 expression following transfection with these lipids while the GFP was detected at low levels ( Figure   3C ).
Together, these data demonstrated that using the electroporation, we achieved the enforced expression of the human CYP2E1 in differentiated HepaRG cells. This drug-metabolizing enzyme is of an enormous toxicological and carcinogenic importance because of its implication in the metabolism of a large number of chemicals such as ethanol, acetaminophen, acrylamide and many cancer suspected agents [10] . Thus, low expression of CYP2E1 in differentiated HepaRG cells was a clear limitation in their use for metabolism and toxicological studies of a wide range of molecules with relevance for human health. Differentiated HepaRG cells expressing high levels of the most important CYPs including the CYP2E1 definitely opens new perspectives for drug metabolism and toxicity studies of a variety of new drugs. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   F  o  r  P  e  e  r  R  e  v  i  e  w  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   F  o  r  P  e  e  r  R  e  v  i  e  w  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 
